Cell-cycle arrest
Original Article MiR-17-5p decreases cell viability by inducing cell cycle arrest in PC12 cells following oxygen and glucose deprivation
7
/M cell cycle arrest in the broiler’s kidney
14
/M cell cycle arrest induced by AFB
15
Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway
17
Vpr-induced cell cycle arrest is conserved among primate lentiviruses.
9
Apoptosis induction, cell cycle arrest and in vitro anticancer activity of gonothalamin in a cancer cell lines
6
Original Article MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2
9
CCAAT/Enhancer Binding Protein α Interacts with ZTA and Mediates ZTA-Induced p21CIP-1 Accumulation and G1 Cell Cycle Arrest during the Epstein-Barr Virus Lytic Cycle
20
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
11
Human Parvovirus B19 Nonstructural Protein (NS1) Induces Cell Cycle Arrest at G1 Phase
7
Original Article FOXO3a expression and its diagnostic value in pancreatic ductal adenocarcinoma
8
Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer
13
Multi scale modelling of the dynamics of cell colonies : insights into cell adhesion forces and cancer invasion from in silico simulations
13
Original Article MiR-22 functions as a biomarker and regulates cell proliferation, cycle, apoptosis, migration and invasion in renal cell carcinoma
13
Acanthamoeba induces cell cycle arrest in host cells
8
MERTK as a novel therapeutic target in head and neck cancer
17
Human Immunodeficiency Virus Type 1 Vpr Binds to the N Lobe of the Wee1 Kinase Domain and Enhances Kinase Activity for Cdc2
11
B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy
18
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
13
ROSMARINIC ACID ENHANCES CISPLATIN CYTOTOXICITY IN HEPG2 CELL LINE AND ATTENUATES ITS NEPHROTOXICITY IN MICE
13